文献速递衰弱、肌少症与跌倒老年综合评估

衰弱测量工具临床意义变化的评估

Evaluation of Clinically Meaningful Changes in Measures of Frailty.
PubMed 文献 · J Gerontol A Biol Sci Med Sci · 2020-01-01

该前瞻性队列研究纳入1135名社区居住老年人,基线及1年后评估衰弱与EuroQol-5D生活质量,采用分布法和锚定法确定四种衰弱工具的临床意义变化值及响应度。结果显示不同衰弱工具的临床意义变化阈值差异较大,FI所需样本量最小,SOF指数最大,这些估计可指导临床试验和临床实践中衰弱工具的选择。

要点

  • FI小/大临床意义变化分布法为0.019/0.057,锚定法为0.028/0.076。
  • 衰弱表型小/大变化分布法为0.249/0.623,锚定法为0.097/0.607。
  • 临床试验每组样本量小变化从51(FI)到7272(SOF指数)不等。

核心结论

  • 四种常用衰弱测量工具的临床意义变化估计值可为临床试验和社区老年人临床照护中选择衰弱工具提供依据。

研究设计与样本

  • 前瞻性队列研究,纳入1135名社区居住老年人,基线及1年后评估衰弱(FI、衰弱表型、FRAIL量表、SOF指数)和EuroQol-5D生活质量。
  • 1年时925名参与者(81.5%)有衰弱测量数据。
  • 采用分布法和基于EuroQol-5D评分的锚定法确定临床意义变化,并计算响应度指数。

主要发现

  • 分布法小/大临床意义变化:FI为0.019/0.057,衰弱表型为0.249/0.623,FRAIL量表为0.235/0.587,SOF指数为0.116/0.289。
  • 锚定法小/大临床意义变化:FI为0.028/0.076,衰弱表型为0.097/0.607,FRAIL量表为0.269/0.368,SOF指数为0.023/0.287。
  • 基于响应度指数,临床试验每组达到80%把握度所需样本量:小变化从51(FI)到7272(SOF指数),大变化从9(FI)到133(FRAIL量表)。

关键数值与推荐

  • FI小临床意义变化0.019(分布法)或0.028(锚定法),大变化0.057(分布法)或0.076(锚定法)。
  • 衰弱表型小临床意义变化0.249(分布法)或0.097(锚定法),大变化0.623(分布法)或0.607(锚定法)。
  • FRAIL量表小临床意义变化0.235(分布法)或0.269(锚定法),大变化0.587(分布法)或0.368(锚定法)。
  • SOF指数小临床意义变化0.116(分布法)或0.023(锚定法),大变化0.289(分布法)或0.287(锚定法)。

临床怎么用

  • 临床追踪社区老年人衰弱纵向变化时,可参考各工具的临床意义变化阈值选择合适测量工具。
  • 设计衰弱相关临床试验时,可根据预期变化大小利用响应度指数估算每组所需样本量。
  • FI在检测小变化时所需样本量最小,SOF指数所需样本量最大。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To determine the clinically meaningful changes and responsiveness of widely used frailty measures. METHODS: We analyzed data from a prospective cohort study of 1,135 community-dwelling older adults who underwent assessments of frailty and health-related quality of life using the EuroQol-5D at baseline and 1 year later. Frailty measures included deficit-accumulation frailty index (FI); frailty phenotype; Fatigue, Resistance, Ambulation, Illness, and Loss of Weight scale; and the Study of Osteoporotic Fracture (SOF) index. We determined the clinically meaningful changes by the distribution-based method and the anchor-based method using the EuroQol-5D score and responsiveness indices. RESULTS: Frailty measures were available in 925 participants at 1 year (81.5%). Based on the distribution-based method, small and large clinically meaningful changes were 0.019 and 0.057 for FI, 0.249 and 0.623 for frailty phenotype, 0.235 and 0.587 for FRAIL scale, and 0.116 and 0.289 for SOF index, respectively. The anchor-based estimates of small and large changes were 0.028 and 0.076 for FI, 0.097 and 0.607 for frailty phenotype, 0.269 and 0.368 for FRAIL scale, and 0.023 and 0.287 for SOF index, respectively. Based on the responsiveness index, per-group sample sizes to achieve 80% power in clinical trials, ranged from 51 (FI) to 7,272 (SOF index) for a small change and 9 (FI) to 133 (FRAIL scale) for a large change. CONCLUSIONS: The estimates of clinically meaningful change of frailty measures can inform the choice of frailty measures to track longitudinal changes of frailty in clinical trials and clinical care of community-dwelling older adults.

来源:J Gerontol A Biol Sci Med Sci,查看原文。版权归原作者所有。

引用

  1. Jang IY, Jung HW, Lee HY, et al. Evaluation of Clinically Meaningful Changes in Measures of Frailty. J Gerontol A Biol Sci Med Sci. 2020. PMID: 32145016. doi:10.1093/gerona/glaa003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。